BCDx Monitoring
Clinical Validation- Indications
- Bladder cancer
Company intelligence / Profile preview
Early is Good
Indianapolis, Indiana, United Statesearlyisgood.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Early is Good has developed non-invasive urine-based diagnostic tests for bladder cancer surveillance and early detection. Their BCDx Monitoring test reportedly achieves a 100% negative predictive value for recurrence monitoring. The company recently received a $1.6M NIH Phase 2 grant to support validation of its bladder cancer monitoring test. They are also collaborating with Mayo Clinic to develop a comprehensive liquid biopsy for advanced prostate cancer[3][4].
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic testMultiomic biomarker detection (includes DNA, RNA, protein, metabolite analysis)
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Mayo Clinic[3][4]
Beyond the preview
Go deeper on Early is Good.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Early is Good.